低剂量rhG—CSF治疗肿瘤化疗所致的白细胞减少症

重组人粒细胞集落刺激因子 (ｒｈＧ ＣＳＦ)是应用基因重组技术生产的糖蛋白 ,能有效调解造血祖细胞的粒系增殖分化 ,可用于治疗恶性肿瘤放疗和化疗引起的白细胞减少症[1] 。我们自 1998年 9月～ 1999年 11月使用国产ｒｈＧ ＣＳＦ治疗肿瘤化疗所致白细胞减少症取得了满意效果。1　材料及方法14例患者中 ,男性 9例 ,女性 5例 ,平均年龄 5 3岁 (32～71岁 )。病理均证实为恶性肿瘤 ,其中小细胞肺癌 4例 ,化疗方案ＣＥ(ＣＢＰ ,ＶＰ16 ) ;非小细胞肺癌 5例 ,化疗方案ＮＰ(ＮＶＢ ,ＤＤＰ) ;胃腺癌 3例 ,化疗方案ＥＦＰ(ＶＰ16 ,5ＦＵ ,ＤＤＰ) …     

重组IL—6与IL—3或／和GM—CSF合用对正常NB大鼠粒单系体外…

本研究探讨了重组人ＩＬ－６与大鼠ＩＬ－３和／或小鼠ＧＭ－ＣＳＦ结合对正常ＢＮ大鼠粒单系体外造血的调控效应。结果表明,ＩＬ－６在１０００－４０００Ｕ／ｍｌ呈剂量依赖性刺激粒系造血祖细胞集落形成及骨髓细胞的ＤＮＡ合成,集落以ＧＭ型为主,其刺激活性低于ＩＬ－３或ＧＭ－ＣＳＦ。ＩＬ－６与ＩＬ－３和或ＧＭ－ＣＳＦ的结合对粒单系集落形成及ＤＮＡ合成无协同或相加作用,甚至出现拮抗效应,但却显著增大集落,提示ＩＬ     

重组人粒系集落刺激因子（rhG—CSF）对白血病细胞HL—60生长 …

本文研究了ｒｈＧ－ＣＳＦ对人白血病细胞系ＨＬ－６０的作用。结果表明：ｒｈＧ－ＣＳＦ能够显著抑制ＨＬ－６０细胞生长和Ｃ－ｍｙｃ基因的表达,降低＾３Ｈ－ＴｄＲ的摄入。在含ｒｈＧ－ＣＳＦ的培养液中经过２－５天的培养,部分ＨＬ－６０细胞具备ＮＢＴ还原能力。这或许说明ｒｈＧ－ＣＳＦ能导致ＨＬ－６０细胞向成熟方向分化的结果。     

TNF—α在PMA和IFN—γ诱导U937细胞生长和分化过程中的作用

本文报道了佛波酯（ＰＭＡ）和γ－干扰素（ＩＦＮ－γ）对Ｕ９３７细胞生长和分化的调控作用及其机制。ＰＭＡ和ＩＦＮ－γ能以剂量依赖的方式诱导Ｕ９３７细胞向成熟单核／巨噬细胞样细胞分化,同时抑制其细胞的生长。实验发现ＰＭＡ和ＩＦＮ－γ可诱导Ｕ９３７细胞表达ＴＮＦ－α特异性ｍＲＮＡ和蛋白质。Ｕ９３７细胞培养中加入特异性抗ＴＮＦ－α抗体可以抑制ＰＭＡ和ＩＦＮ－γ诱导Ｕ９３７细胞的分化和生长。这说明内源性的Ｔ     

用逆转录病毒载体表达人粒细胞－巨噬细胞集落刺激因子

应用基因工程的方法,将含有巨细胞病毒（ＣＭＶ）启动子的基因片段和人粒细胞－巨噬细胞集落刺激因子（ｈＧＭ－ＣＳＦ）的ｃＤＮＡ,克隆进逆转录病毒载体Ｎ２Ａ,得到重组质粒Ｎ２Ａ／ＣＭＶ／ｈＧＭ－ＣＳＦ．经脂质体包装并转染包装细胞,通过Ｇ４１８药物筛选,得到抗性克隆。经ＰＣＲ和Ｓｏｕｔｈｅｍｂｌｏｔ检测证实,ＧＭ－ＣＳＦ基因已整合到该克隆细胞的染色体上,获得的逆转录病毒滴度达１０￣４ＣＦＵ／ｍｌ,克隆细胞培养上清用ＴＦ－１细胞可检测到ＧＭ－ＣＳＦ活性。     

锂对小鼠高增殖潜能集落形成细胞和粒巨噬系祖细胞体外增殖的影响

本文观察了锂对ＢＡＬＢ／Ｃ小鼠骨髓高增殖潜能集落形成细胞（ＨＰＰ－ＣＦＣ）和粒巨噬系祖细胞ＣＦＵ－ＧＭ体外增殖的影响。ＨＰＰ－ＣＦＣ集落由ＩＬ－１、ＩＬ－６、ＷＥＨＩ３条件培养液（ＷＥＨＩ３－ＣＭ,含有ＩＬ－３）及Ｌ９２９条件培养液（Ｌ９２９－ＣＭ,含有Ｍ－ＣＳＦ）所支持,而ＣＦＵ－ＧＭ由ＷＥＨＩ３－ＣＭ所支持。结果显示,ＬｉＣｌ浓度在０．４－２ｍｍｏｌ／Ｌ时呈现剂量依赖性抑制ＨＰＰ－ＣＦＣ增殖;而在０．４－１ｍｍｏｌ／Ｌ的浓度范围内,则对ＣＦＵ－ＧＭ的增殖起剂量依赖性促进作用。这些结果提示ＬｉＣｌ对ＨＰＰ－ＣＦＣ和ＣＦＵ－ＧＭ的作用不同,可能锂有诱导ＨＰＰ－ＣＦＣ向成熟细胞分化的作用     

骨髓高增殖潜能集落形成细胞（HPP—CFC）分化产生巨核细胞的研究

本研究用正常和５－ＦＵ处理的小鼠骨髓细胞,作血浆凝块培养,对一种称作ＨＰＰ－ｍＣＦＵ－ＭＫ的ＨＰＰ－ＣＦＣ亚型细胞集落进行体外追踪。发现ＨＰＰ－ｍＣＦＵ－ＭＫ不但能形成符合ＨＰＰ－ＣＦＣ标准的巨大集落,而且能产生大量的巨核细胞。该巨大集落的生长,依赖添加再生障碍性贫血猪血清（ＡＡＳ）或合用三种以上的基因重组造血生长因子而增强,在体外不被ＴＧＦ－β１和ＰＦ４抑制。原代培养１２天所得到的ＨＰＰ－ｍＣＦ     

锂对小鼠高增殖潜能集落形成细胞和粒巨噬系祖细胞体外增殖…

本文观察了锂对ＢＡＬＢ／Ｃ小鼠骨髓高增殖潜能集落形成细胞和粒巨噬系祖细胞ＣＦＵ－ＧＭ体外增殖的影响。ＨＰＰ－ＣＦＣ集落由ＩＬ－１,ＩＬ－６,ＷＥＨＩ３条件培养液及Ｌ９２９条件培养液所支持,而ＣＦＵ－ＧＭ由ＷＥＨＩ３－ＣＭ所支持。结果显示,ＬｉＣｌ浓度在０．４－２ｍｍｏｌ／Ｌ时呈现剂量依赖性抑制ＨＰＰ－ＣＦＣ增殖;而在０．４－１ｍｍｏｌ／Ｌ的浓度范围内,则对ＣＦＵ－ＧＭ的增殖起剂量依赖性促进作用。     

人GM—CSF cDNA的克隆和在大肠杆菌中的表达

从诱导的人胚肺细胞ＨＦＬ株中提取总ＲＮＡ．经ＲＴ－ＰＣＲ反应获取了人ＧＭ－ＣＳＦｃＤＮＡ,ＤＮＡ序列测定表明其顺序与文献报道完全一致。为了获得高效表达,应用ＰＣＲ改造了人ＧＭ－ＣＳＦ的ｃＤＮＡ５’端核苷酸序列,并将改造的人ＧＭ－ＣＳＦ基因插入含Ｔ７启动子的质粒ｐＥＴ－１１ｄ构建成表达质粒ｐＥＴＣ－５,将此质粒转化大肠杆菌株ＢＬ２１（ＤＥ３）得到表达菌株ＢＬＥＣ４。表达菌株用０．５ｍｏｌ／ＬＩＰＴＧ诱导２小时后,产生大量重组蛋白并形成包涵体。ＳＤＳ—ＰＡＧＥ电泳图谱扫描结果表明,ｒｈＧＭ－ＣＳＦ产量占菌体总蛋白量的１６％。ＥＬＩＳＡ和ＴＦ－１细胞培养测定表明,初步纯化和复性的ｒｈＧＭ－ＣＳＦ具有天然的ｈＧＭ－ＣＳＦ生物活性。     

骨髓内皮细胞产物对CFU-F、CFU-GM和WEHI-3细胞生长的作用

为了研究骨髓内皮细胞的造血调控功能,采用串联超波技术脞小鼠骨髓内皮细胞无血清条件培养液（ｍＢＭＥＣ－ＣＭ）中制血出不同相对分子质量（Ｍｇｔ）范围的超滤组分,进行细胞集落形成实难,检测了ｍＢＭＥＣ－ＣＭ及其超滤组分对骨髓成纤维祖细胞（ＣＦＵ－Ｆ）、粒巨噬系造血祖细胞（ＣＦＵ－ＧＭ）和小鼠业单系白现细胞系ＷＥＨＩ－３细胞生长的作用。结果显示：ｍＢＭＥＣ－ＣＭ抑制ＣＦＵ－Ｆ的生长,对ＣＦＵ－ＧＭ和ＷＥＨ     

p~(53)基因在U 937细胞生长和分化过程中的调节作用

本文报道了p~(53)基因对人白血病细胞系U 937细胞生长和分化的调节作用。重组人GM-CSF(rhGM-CSF)可诱导U 937细胞向成熟巨噬细胞分化,这反映在分化后的细胞表达有巨噬细胞许多表型特征和功能活性。在这一分化过程中同时伴随着p~(53)基因的表达增加和U 937细胞生长受抑。进一步,用反义脱氧寡聚核苷酸抑制试验特异性地抑制p~(53)基因表达,结果发现p~(53)反义脱氧寡聚核苷酸可以明显抑制rhGM-CSF诱导U 937细胞向成熟巨噬细胞分化,同时也明显解除rhGM-CSF介导细胞分化过程中的细胞生长抑制作用。这些结果说明p~(53)基因在U 937细胞的生长和分化过程中可能起偶联调控作用。     

P^53基因在U937细胞生长和分化过程中的调节作用

The expression of p53 gene has been found to be regulated during the induction of differentiation of U937 leukemic cells into mature macrophages by recombinant human granulocyte- macrophage colony stimulating factors (rhGM-CSF) We showed here that the increased expression of p53 seemed to be necessary for the differentiation of U937 cells induced by rh-GM-CSF. The inhibition of p53 expression by a p53 antisense oligodeoxynucleotide lead to the significant decrease of formation of mature macrophages from U 937 cells in the presence of rhGM-CSF. By contrast, the p53 sense oligodeoxynucleotide had no any effect. Furthermore, we have analysed the growth of U937 cells in the presence or absence of rhGM-CSF. The results showed that rhGM-CSF dramatically inhibited the growth of U 937 cells in the cultures. At the same time, the antisense inhibition experiment demonstrated that the inhibition of p53 expression partially diminished the growth-inhibitory effect of rhGM-CSF on U 937 cells. These results suggested that the p53 was required for the initiation of rhGM-CSF-induced differentiation of U 937 cells on one hand, and the inhibition of cell growth on the other hand. Thus we deduce that the increased expression of p53 induced by rhGM-CSF may be a coupling event of switch of U 937 cells from growth into differentiation.     

HFCL细胞对U937细胞的诱导分化作用

为了观察正常人骨髓成纤维样细胞系HFCL对急性单核细胞白血病U937细胞促分化作用,及其对经典诱导分化剂TPA诱导分化作用的影响,先建立U937细胞和HFCL细胞共培养体系,以细胞形态学改变、硝基四氦唑蓝(NBT)、流式细胞仪检测细胞周期和CD11b、CD13、CD14、CD33细胞表面抗原作为诱导分化指标;Western印迹检测P38蛋白的表达变化。结果发现,与HFCL细胞共培养后,U937细胞出现分化成熟的形态学改变,且与HFCL细胞直接接触组的诱导分化作用大于用transwell组。同时发现U937细胞与HFCL细胞共培养后,G1期细胞增高,S期细胞减少;CD11b、CD13、CD14和CD33表达增高;且NBT阳性细胞增高至46、3％。Western印迹检测结果显示,直接接触组总P38蛋白表达增加。而且HFCL细胞还能增强TPA对U937的诱导分化作用。     

Simian immunodeficiency virus inhibits bone marrow hematopoietic progenitor cell growth.

The pathogenic mechanisms underlying the depressed hematopoietic functions seen in human immunodeficiency virus-infected individuals were explored in rhesus monkeys infected with the simian immunodeficiency virus of macaques (SIVmac). Bone marrow hematopoietic progenitor cell colony formation, both granulocyte/macrophage (CFU-GM) and erythrocyte (BFU-E), was shown to be decreased in number in SIVmac-infected rhesus monkeys. SIVmac was readily isolated from bone marrow cells of infected monkeys and was shown to be harbored in macrophages rather than T lymphocytes. The in vitro infection of normal bone marrow cells by SIVmac inhibited colony formation. A striking in vivo correlation between increased SIVmac load in bone marrow cells and decreased hematopoietic progenitor cell colony growth was also shown. Finally, inhibition of SIVmac replication in bone marrow macrophages resulted in increased progenitor cell colony growth from bone marrow cells. These results suggest that the infection of bone marrow macrophages by the acquired immunodeficiency syndrome (AIDS) virus may contribute to depressed bone marrow hematopoietic progenitor cell growth. Moreover, inhibition of AIDS virus replication in these macrophages might induce significant improvement in hematopoietic function.     

Effect of Zinc Upon Human and Murine Cell Viability and Differentiation

Most zinc studies show its benefits or changes that coincide with its deficiency, but some have reported damages by supplements. In this work, the effects of zinc in different cell lines (U-937, human monocytes, and murine bone marrow cells) were analyzed. The cells were put in their specific culture medium either alone or with a stimulant [1-phorbol 12-myristate 13-acetate (PMA) for U-937 and monocytes, granulocyte macrophage colony stimulating factor (GM-CSF) for bone marrow cells]. These preparations, with or without zinc (0.05 to 1.0 mM), were incubated and microscopically analyzed on days 3, 9, and 11. The viability of all cells cultivated with 0.05 and 0.1 mM of zinc was similar to that of the controls without zinc (90%). With 1.0 mM of zinc, the viability diminished (p < 0.005) to 80% in U-937 and to 50% in monocytes and bone marrow cells; the number of cells increased in the three lines, but there was no differentiation. We conclude that the effects observed with different doses of zinc vary not only among the different species but also according to the time the cells were exposed to the metal. The same doses of zinc can have either a stimulatory or an inhibitory effect.     

Different recovery patterns of mouse haemopoietic stem cells in response to cytotoxic agents

The response and subsequent recovery of mouse haemopoietic progenitor cells (spleen colony forming cells and agar colony forming cells) has been studied following two cytotoxic agents. Busulphan was administered to normal mice and vinblastine to mice where the progenitor cell proliferation rate had been increased by a period of continuous γ-irradiation. With both these agents there is a difference between the response of the spleen colony forming cells and the agar colony forming cells during the first five days. They then recover together, but much more slowly after busulphan than after vinblastine even though their proliferation rate is increased. The rate of progenitor cell recovery after busulphan is increased if the progenitor cells are depleted further by vinblastine. However, methotrexate, which severely depletes the peripheral blood count and bone marrow cellularity but not the progenitor cells, has no effect on the recovery following busulphan. These results suggest that following cytotoxic agents the agar colony forming cells (“committed” stem cells) are not self-maintaining but are dependent on a supply of cells from the pluripotential spleen colony forming cells. In addition it appears that the depletion of the progenitor cells of the bone marrow and not the depletion of the maturing cells, provides a stimulus for stem cell recovery.     

Placental Growth Factor Expression Is Required for Bone Marrow Endothelial Cell Support of Primitive Murine Hematopoietic Cells

Two distinct microenvironmental niches that regulate hematopoietic stem/progenitor cell physiology in the adult bone marrow have been proposed; the endosteal and the vascular niche. While extensive studies have been performed relating to molecular interactions in the endosteal niche, the mechanisms that regulate hematopoietic stem/progenitor cell interaction with bone marrow endothelial cells are less well defined. Here we demonstrate that endothelial cells derived from the bone marrow supported hematopoietic stem/progenitor cells to a higher degree than other endothelial or stromal cell populations. This support was dependant upon placental growth factor expression, as genetic knockdown of mRNA levels reduced the ability of endothelial cells to support hematopoietic stem/progenitor cells in vitro. Furthermore, using an in vivo model of recovery from radiation induced myelosuppression, we demonstrate that bone marrow endothelial cells were able to augment the recovery of the hematopoietic stem/progenitor cells. However, this effect was diminished when the same cells with reduced placental growth factor expression were administered, possibly owing to a reduced homing of the cells to the bone marrow vasculature. Our data suggest that placental growth factor elaborated from bone marrow endothelial cells mediates the regulatory effects of the vascular niche on hematopoietic stem/progenitor cell physiology.     

Rabies virus replication in primary murine bone marrow macrophages and in human and murine macrophage-like cell lines: implications for viral persistence.

To determine whether rabies viruses replicate in macrophage or macrophage-like cells, several human and murine macrophage-like cell lines, as well as primary cultures of murine bone marrow macrophages, were incubated with the Evelyn-Rokitnicki-Abelseth (ERA) virus and several different street rabies viruses (SRV). ERA rabies virus replicated well in human monocytic U937 and THP-1 cells and murine macrophage IC-21 cells, as well as primary cultures of murine macrophages. Minimal replication was detected in murine monocytic WEHI-3BD- and PU5-1R cells, and ERA virus did not replicate in murine monocytic P388D1 or J774A.1 cells. A tissue culture-adapted SRV of bat origin also replicated in IC-21 and U937 cells. Non-tissue culture-adapted SRV isolated from different animal species, particularly bats, replicated minimally in U937, THP-1, IC-21 cells and primary murine bone marrow macrophages. To determine whether rabies virus replication is dependent upon the state of differentiation of the macrophage-like cell, human promyelocytic HL-60 cells were differentiated with 12-O-tetradecanoylphorbol-13-acetate (TPA). ERA rabies virus replicated in the differentiated HL-60 cells but not in undifferentiated HL-60 cells. Persistent infections were established in macrophage-like U937 cells with ERA rabies virus and SRV, and infectious SRV was isolated from adherent bone marrow cells of mice that had been infected 96 days previously. Virus harvested from persistently infected U937 cells and the adherent bone marrow cells had specifically adapted to each cell. This specificity was shown by the inability of the viruses to infect macrophages other than U937 cells and primary bone marrow macrophages, respectively. Virus titers of the persistently infected U937 cells fluctuated with extended cell passage. After 30 passages, virus released from the cells had lost virulence as shown by its inability to kill intracranially inoculated mice. However, the avirulent virus released from the persistently infected cells was more efficient in infecting and replicating in naive U937 cells than the virus which was used to establish the persistent infection. These results suggest that macrophages may serve as reservoirs of infection in vivo, sequestering virus which may subsequently be activated from its persistent state, resulting in clinical infection and death.     

Cimetidine induced pancytopenia. Effect on human CFU-MIX colony formation

We describe a 26 year-old male with a pancytopenia possibly due to cimetidine. Using progenitor cell culture techniques we investigated the mechanism of this bone marrow toxicity. Our results show a cimetidine dose-dependent inhibition of normal human CFU-GM colony formation as described by Fitchen and Koeffler in 1980. No differences in growth inhibition were found between the patients' recovery marrow and the controls. Toxicity on normal human CFU-MIX colony formation was, however, far more pronounced. At concentrations as low as 5 micrograms/ml the numbers of CFU-MIX colonies were decreased by almost 20% and more than 30% in cultures of two normal bone marrow samples. A significant decrease in CFU-MIX colony size was measured even at therapeutic levels (0.5 micrograms/ml). No obvious decrease in CFU-GM colony size was noticed at low concentrations. Experiments with T-cell- and monocyte-depleted bone marrow samples gave similar results: a pronounced inhibition of the CFU-MIX colony formation at low concentrations of cimetidine whereas the CFU-GM formation was less affected. It is therefore very unlikely that Accessory cells play part in the cimetidine induced CFU-MIX inhibition. Our results suggest the existence of H2 histamine receptors on human CFU-MIX (= multipotent progenitor cell). Blocking these receptors prevents the multipotent progenitor cell from going into the DNA-synthesis phase of the cell cycle.     

The effect of natural killer cells on the development of syngeneic hematopoietic progenitors

To determine whether natural killer (NK) cells are involved in the regulation of hematopoiesis, well-characterized, cell sorter-purified NK cells were incubated with syngeneic bone marrow, and the effect of this interaction on the development of various hematopoietic progenitors was assessed. NK cells were obtained from the peritoneal exudates of CBA/J mice after i.p. infection with live Listeria monocytogenes (LM). These NK cells were nylon wool-nonadherent and were purified by using M1/70, a rat anti-murine macrophage monoclonal antibody, and a fluorescence-activated cell sorter (FACS). Syngeneic bone marrow was incubated overnight with these M1/70-purified NK cells. The cells were then assayed in vitro to determine the effect on the colony formation of the following hematopoietic progenitor cells: the myeloid progenitor that produces mixed granulocyte/macrophage colonies (CFU-G/M), the myeloid progenitor that is committed to macrophage differentiation (CFU-M), and the early erythroid progenitor that is known as the burst-forming unit-erythroid (BFU-E). The marrow cells, after incubation with NK cells, were also injected into lethally irradiated syngeneic recipients to assay for the splenic colony formation capacity of the trilineage myeloid stem cell (CFU-S). Although the formation of BFU-E-, CFU-G/M-, and CFU-M-derived colonies was not adversely affected by the exposure of syngeneic bone marrow to purified NK cells, there was a dramatic decrease in the number of CFU-S-derived colonies. Incubation with NK-depleted cells did not result in an inhibition of colony formation by the CFU-S. Mixing experiments showed that the M1/70-labeled NK cells exerted their effect directly on the CFU-S and not on any accessory cells. The effect of the NK cells on colony formation by the CFU-S could be blocked competitively and selectively by the addition, before incubation, of a classic murine NK tumor target, Yac-1. Another tumor line (WTS) that is poorly recognized by NK cells was less effective in blocking the inhibitory effect of NK cells on CFU-S. The demonstration that purified NK cells can selectively inhibit the development of the tripotential CFU-S may point to the importance of NK cells in the regulation of hematopoiesis, in the development of some types of marrow dysfunction, and in the failure of engraftment of transplanted bone marrow.